Establishing the standards of operational excellence to manufacture commercial cell therapies

Abigail Pinchbeck, Editor, BioInsights, speaks to Melanie Mansbach, Head of Cell Therapy Manufacturing, Lonza Houston, and Hui Zheng, Head of CGT Operations, Lonza Singapore

Please enter your email to access content Read now